Follow the 신흥 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 신흥 has logged 141 public disclosures. Market capitalisation: €127.5bn. The latest transaction was reported on 29 May 2026 (Purchase). Among the most active insiders: 이용익. All data is openly available.
141
Insider Decl.
0
Thresholds
€639,089
16 ops.
Buy Volume
€397,056
30 ops.
Sell Volume
30Σ signal
Buys €639,089€397,056 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 17,013 of 26,212 companies
42.2
score / 100
Value
38
Quality
46
FCF yld-1.2%
Earn yld2.2%
EV/EBITDA15.1x
ROE3.0%
Gross mgn31%
Net mgn2.8%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
